The second group featured characteristics such as complete 3-months response, the absence of relapse, the absence of cancer-related death, the non-overexpression of HIF-1 alpha, Hb > 11 g/dl and a chemoradiation treatment. The gene discussed is GSTM1; the disease is cancer.